Business Description
Indo US Bio-Tech Ltd
ISIN : INE250Z01010
Share Class Description:
NSE:INDOUS: Ordinary SharesTotal Employee Number:
883Compare
Compare
Traded in other countries / regions
541304.India IPO Date
2024-09-27Description
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.4 | |||||
Debt-to-EBITDA | 2.17 | |||||
Interest Coverage | 7.18 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 4.56 | |||||
Beneish M-Score | -1.73 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.8 | |||||
3-Year EBITDA Growth Rate | 20.7 | |||||
3-Year EPS without NRI Growth Rate | 21.9 | |||||
3-Year FCF Growth Rate | -123.2 | |||||
3-Year Book Growth Rate | 19.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.45 | |||||
9-Day RSI | 41.88 | |||||
14-Day RSI | 39.63 | |||||
3-1 Month Momentum % | -12.94 | |||||
6-1 Month Momentum % | -19.01 | |||||
12-1 Month Momentum % | -40.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.05 | |||||
Quick Ratio | 0.52 | |||||
Cash Ratio | 0.17 | |||||
Days Inventory | 350.91 | |||||
Days Sales Outstanding | 68.46 | |||||
Days Payable | 4.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -9.89 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 27.32 | |||||
Operating Margin % | 14.59 | |||||
Net Margin % | 11.88 | |||||
EBITDA Margin % | 15.45 | |||||
FCF Margin % | -13.57 | |||||
OCF Margin % | -11.39 | |||||
ROE % | 15.28 | |||||
ROA % | 11.31 | |||||
ROIC % | 13.52 | |||||
3-Year ROIIC % | 11.61 | |||||
ROC (Joel Greenblatt) % | 15.38 | |||||
ROCE % | 18.42 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.37 | |||||
PE Ratio without NRI | 13.37 | |||||
Shiller PE Ratio | 22.1 | |||||
PEG Ratio | 0.72 | |||||
PS Ratio | 1.59 | |||||
PB Ratio | 1.9 | |||||
Price-to-Tangible-Book | 1.9 | |||||
EV-to-EBIT | 12.71 | |||||
EV-to-EBITDA | 12.04 | |||||
EV-to-Revenue | 1.86 | |||||
EV-to-FCF | -13.71 | |||||
Price-to-GF-Value | 0.28 | |||||
Price-to-Projected-FCF | 5.72 | |||||
Price-to-DCF (Earnings Based) | 0.56 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.72 | |||||
Price-to-Graham-Number | 1.06 | |||||
| Price-to-Net-Current-Asset-Value | 2.19 | |||||
Earnings Yield (Greenblatt) % | 7.87 | |||||
FCF Yield % | -8.55 | |||||
Forward Rate of Return (Yacktman) % | 16.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Indo US Bio-Tech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,104.391 | ||
| EPS (TTM) (₹) | 6.54 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 46.02 | ||
| 14-Day RSI | 39.63 | ||
| 14-Day ATR (₹) | 4.369959 | ||
| 20-Day SMA (₹) | 89.064 | ||
| 12-1 Month Momentum % | -40.8 | ||
| 52-Week Range (₹) | 85.51 - 206 | ||
| Shares Outstanding (Mil) | 20.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Indo US Bio-Tech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Indo US Bio-Tech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 0.250000 Cash Dividend | 2024-12-03 | 308.80 (+17.19%) |
Show
Entries
Indo US Bio-Tech Ltd Frequently Asked Questions
What is Indo US Bio-Tech Ltd(NSE:INDOUS)'s stock price today?
The current price of NSE:INDOUS is ₹87.52. The 52 week high of NSE:INDOUS is ₹206.00 and 52 week low is ₹85.51.
When is next earnings date of Indo US Bio-Tech Ltd(NSE:INDOUS)?
The next earnings date of Indo US Bio-Tech Ltd(NSE:INDOUS) is .
Does Indo US Bio-Tech Ltd(NSE:INDOUS) pay dividends? If so, how much?
Indo US Bio-Tech Ltd(NSE:INDOUS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Indo US Bio-Tech Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers